(Q42992996)

English

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics

scientific article published on 7 June 2013

Statements

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics (English)
Benedict Maliakkal
Mohamed Al-Ibrahim
Juergen Kurt Rockstroh
Michelle Miller
Richard Barnard
Peggy May Hwang
Jacqueline Gress
Niloufar Mobashery

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit